The CLEAR Outcomes Trial: Bempedoic Acid and CV Outcomes in Statin-Intolerant Patients —A Clear Glimmer of Hope The CLEAR Outcomes Trial: Bempedoic Acid and CV Outcomes in Statin-Intolerant Patients —A Clear Glimmer of Hope

This review highlights the groundbreaking results of the CLEAR Outcomes trial, showing that among statin-intolerant patients, treatment with bempedoic acid was associated with a lower risk of major adverse cardiovascular events.ACC.org
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news